A Posthoc Analysis of Eszopiclone Effects on Cardiometabolic Indices of Hyperarousal in the Treatment of Primary Insomnia
نویسندگان
چکیده
Introduction: Antipsychotics are often used to manage the affective (manic and depressive) and psychotic symptoms of patients with schizoaffective disorder. However, it is difficult to determine whether observed improvements in depressive symptoms are achieved through effects on depressive symptoms or effects on psychotic symptoms. This analysis evaluated the effect of antipsychotic treatment on depressive symptoms after accounting for effects on positive and negative psychotic symptoms and extrapyramidal symptoms in subjects with schizoaffective disorder.
منابع مشابه
Eszopiclone versus zopiclone in the treatment of insomnia
OBJECTIVE To determine the therapeutic effects of two selective GABA-A agonists, zopiclone and eszopiclone, in the treatment of insomnia. METHODS This study comprised a phase III, single-center, randomized, double-blind, double-dummy, parallel-group, non-inferiority trial. Patients were randomized to receive zopiclone 7.5 mg or eszopiclone 3 mg, both orally, for four weeks. In total, 199 pati...
متن کاملEszopiclone: its use in the treatment of insomnia
Eszopiclone is the S-isomer of racemic zopiclone, a cyclopyrrolone with sedative-hypnotic activity that has been available in Europe, Canada, and Latin America since 1987. Eszopiclone acts by binding to the GABA(A) receptor. In contrast to the benzodiazepine (BZD) hypnotics, eszopiclone has more selectivity for certain subunits of the GABA(A) receptor. Oral eszopiclone is rapidly absorbed and e...
متن کاملEszopiclone for insomnia associated with attention-deficit/hyperactivity disorder.
OBJECTIVE To evaluate efficacy and safety of eszopiclone compared with placebo in children and adolescents with insomnia associated with attention-deficit/hyperactivity disorder (ADHD). METHODS A 12-week, randomized, double-blind, placebo-controlled trial evaluated efficacy and safety of high- or low-dose eszopiclone (1 or 2 mg in children aged 6-11 years, 2 or 3 mg in children ages 12-17 yea...
متن کاملEszopiclone for late-life insomnia
Insomnia, the most common sleep disturbance in later life, affects 20%-50% of older adults. Eszopiclone, a short-acting nonbenzodiazepine hypnotic agent developed for the treatment of insomnia, has been available in Europe since 1992 and in the US since 2005. Although not yet evaluated for transient insomnia in older adults, eszopiclone has been shown to be safe and efficacious for short-term t...
متن کاملCost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia.
STUDY OBJECTIVE To assess the cost-effectiveness of treatment with eszopiclone for chronic primary insomnia in adults. METHODS A model using patient-level data from a 6-month, double-blind, placebo-controlled, clinical trial (n = 824), combined with data from a claims database and published literature, was used to assess the quality-adjusted life years (QALYs) gained and costs associated with...
متن کامل